Vigonvita Life Sciences Co., Ltd. (HKG:2630)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
99.00
+2.70 (2.80%)
At close: Mar 6, 2026
Market Cap16.59B
Revenue (ttm)12.59M -94.1%
Net Income-224.97M
EPS-1.55
Shares Out167.60M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume109,600
Average Volume92,286
Open96.30
Previous Close96.30
Day's Range94.00 - 101.00
52-Week Range51.00 - 134.90
Betan/a
RSI43.31
Earnings Daten/a

About Vigonvita Life Sciences

Vigonvita Life Sciences Co., Ltd., a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas. Its lead products include LV232, a first-in-class dual-target serotonin transporter/5-hydroxytryptamine 3 receptor modulators, which is in Phase II of clinical trial for the treatment of depressive disorder; and TPN171, a type-5 phosphodiesterase inhibitor completed Phase III clinical trial for the tre... [Read more]

Industry Pharmaceutical Preparations
Founded 2013
Country China
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2630
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements